MeSH Review:
Mastocytoma
- Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity. North, R.J., Neubauer, R.H., Huang, J.J., Newton, R.C., Loveless, S.E. J. Exp. Med. (1988)
- Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., Hellström, K.E. J. Exp. Med. (1994)
- Altered immunologic responsiveness in mastocytoma-bearing mice. Kamo, I., Patel, C., Friedman, H. J. Natl. Cancer Inst. (1976)
- Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers. Strik, M.C., Wolbink, A., Wouters, D., Bladergroen, B.A., Verlaan, A.R., van Houdt, I.S., Hijlkema, S., Hack, C.E., Kummer, J.A. Blood (2004)
- Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation. Greenbaum, L.M., Grebow, P., Johnston, M., Prakash, A., Semente, G. Cancer Res. (1975)
- A model of cell cycle control: effects of thymidine on synchronous cell cultures. Thomas, D.B., Lingwood, C.A. Cell (1975)
- Enzymatic assembly of slow reacting substance. Jakschik, B.A., Lee, L.H. Nature (1980)
- A naturally occurring soluble isoform of murine Fas generated by alternative splicing. Hughes, D.P., Crispe, I.N. J. Exp. Med. (1995)
- The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells. Kurosaki, T., Gander, I., Wirthmueller, U., Ravetch, J.V. J. Exp. Med. (1992)
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. Azuma, M., Cayabyab, M., Buck, D., Phillips, J.H., Lanier, L.L. J. Exp. Med. (1992)
- Stimulus specificity of the generation of leukotrienes by dog mastocytoma cells. Goetzl, E.J., Phillips, M.J., Gold, W.M. J. Exp. Med. (1983)
- Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. Sekizawa, K., Caughey, G.H., Lazarus, S.C., Gold, W.M., Nadel, J.A. J. Clin. Invest. (1989)
- Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. Fang, K.C., Raymond, W.W., Lazarus, S.C., Caughey, G.H. J. Clin. Invest. (1996)
- Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice. Warrington, R.C., Cheng, I., Fang, W.D. J. Natl. Cancer Inst. (1987)
- Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine. Boehm, T.L., Drahovsky, D. Cancer Res. (1982)
- Human beta 2-microglobulin specifically enhances cell-surface expression of HLA class I molecules in transfected murine cells. Perarnau, B.M., Gillet, A.C., Hakem, R., Barad, M., Lemonnier, F.A. J. Immunol. (1988)
- Biosynthesis of heparin. Concerted action of late polymer-modification reactions. Jacobsson, I., Lindahl, U. J. Biol. Chem. (1980)
- Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I. Wolters, P.J., Raymond, W.W., Blount, J.L., Caughey, G.H. J. Biol. Chem. (1998)
- Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. Salazar-Onfray, F., Charo, J., Petersson, M., Freland, S., Noffz, G., Qin, Z., Blankenstein, T., Ljunggren, H.G., Kiessling, R. J. Immunol. (1997)
- Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. Mita, S., Harada, N., Naomi, S., Hitoshi, Y., Sakamoto, K., Akagi, M., Tominaga, A., Takatsu, K. J. Exp. Med. (1988)
- Early transmembrane events in alloimmune cytotoxic T-lymphocyte activation as revealed by stopped-flow fluorometry. Utsunomiya, N., Tsuboi, M., Nakanishi, M. Proc. Natl. Acad. Sci. U.S.A. (1986)
- Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Tsujimura, T., Morii, E., Nozaki, M., Hashimoto, K., Moriyama, Y., Takebayashi, K., Kondo, T., Kanakura, Y., Kitamura, Y. Blood (1996)
- Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Piao, X., Paulson, R., van der Geer, P., Pawson, T., Bernstein, A. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. Gajewski, T.F., Fallarino, F., Uyttenhove, C., Boon, T. J. Immunol. (1996)
- Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. Aikawa, J., Esko, J.D. J. Biol. Chem. (1999)
- Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation. Ebata, T., Mogi, S., Hata, Y., Fujimoto, J.I., Yagita, H., Okumura, K., Azuma, M. Eur. J. Immunol. (2001)
- Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2. Schröter, M., Lowin, B., Borner, C., Tschopp, J. Eur. J. Immunol. (1995)
- Combined-modality oncotherapy with cyclophosphamide (NSC-26271) and radiotherapy: control of murine mastocytoma. Schenken, L.L., Hagemann, R.F., Burholt, D.R., Lesher, S. J. Natl. Cancer Inst. (1976)
- Biosynthesis of heparin. Different molecular forms of O-sulfotransferases. Wlad, H., Maccarana, M., Eriksson, I., Kjellén, L., Lindahl, U. J. Biol. Chem. (1994)
- Degradation of heparin proteoglycan in cultured mouse mastocytoma cells. Jacobsson, K.G., Lindahl, U. Biochem. J. (1987)
- Spontaneous immune rejection of intraocular tumors in mice. Niederkorn, J.Y., Meunier, P.C. Invest. Ophthalmol. Vis. Sci. (1985)
- A novel approach for modifying tumor cell-derived plasma membrane vesicles to contain encapsulated IL-2 and engrafted costimulatory molecules for use in tumor immunotherapy. van Broekhoven, C.L., Altin, J.G. Int. J. Cancer (2002)